Stephen G. Dilly
2020 - ProNAi Therapeutics
In 2020, Stephen G. Dilly earned a total compensation of $8.2M as President and Chief Executive Officer at ProNAi Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $175,000 |
|---|---|
| Option Awards | $7,642,630 |
| Salary | $350,000 |
| Other | $4,045 |
| Total | $8,171,675 |
Dilly received $7.6M in option awards, accounting for 94% of the total pay in 2020.
Dilly also received $175K in non-equity incentive plan, $350K in salary and $4K in other compensation.
Rankings
In 2020, Stephen G. Dilly's compensation ranked 1,127th out of 13,090 executives tracked by ExecPay. In other words, Dilly earned more than 91.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,127 out of 13,090 | 91st |
Division Manufacturing | 394 out of 5,624 | 93rd |
Major group Chemicals And Allied Products | 136 out of 2,257 | 94th |
Industry group Drugs | 120 out of 1,957 | 94th |
Industry Pharmaceutical Preparations | 88 out of 1,462 | 94th |
Source: SEC filing on April 23, 2021.
Dilly's colleagues
We found three more compensation records of executives who worked with Stephen G. Dilly at ProNAi Therapeutics in 2020.